the unknown x [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2013-02-11 15:40 (4519 d 13:37 ago) – Posting: # 10002
Views: 10,872

Dear Detlew!

❝ Can you give me a statement on the validity of power.scABEL() and sampleN.scABEL()?


Cross-validating two simulations? :-D

❝ Maybe some of the differences in case of regulator="FDA" are due to the widened ABEL approach instead of the approach via the linearized SABE criterion and its 95% upper confidence limit <0.


Yes, may be another cause.

❝ Again: Coming soon ... or later ... :cool:


Relax.

❝ But if you ask them: Ask in this respect if they have used "The unknown x" used in the SAS code of the progesterone guidance in their implementation of the linearized SABE criterion. I haven't found any hint in their papers on HVD/HVDP regarding such a 'correction' for the upper CI part of the point estimator.


Right guess, IMHO. Remember this thread? I’m short in time right now; if you want I can give you their e-mail addresses and you do it yourself.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,686 registered users;
38 visitors (0 registered, 38 guests [including 11 identified bots]).
Forum time: 06:18 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5